Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06837454 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

Study acronym: FRAME
StatusActive, Not Recruiting
PhaseNot specified
SponsorSanofi
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Study sites: 62 to 61
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 7 of 20 entries
  2. Study sites: 60 to 62v6
  3. Trial sites expanded: 57 → 60 locationsv5
  4. Study sites: 56 to 57
    • Eligibility criteria expanded, about 20 words
    v4
  5. Study sites: 39 to 56v3
  6. Study sites: 1 to 39
    • Primary and study completion dates: Apr 9, 2027 to May 13, 2027
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sanofi
284 trials monitored
See 12 trials at risk
Atopic Dermatitis
500 trials monitored
See 16 trials at risk
The objective of the study is to describe the therapeutic management of patients more than or equal to 18 years old eligible for systemic therapy or treated by systemic therapy for atopic dermatitis (AD). This study will be proposed to a sample of French dermatologists experienced in the management of AD, practicing in hospital centers and/or office-based dermatologists. The study will be conducted in real conditions of practice, systemic treatment decisions will be taken at the sole initiative of the participating physician irrespective of the patient enrollment decision. Each patient will be followed-up in routine care setting for 1 year.
Trial Details
NCT Number NCT06837454
Lead Sponsor Sanofi
Conditions
(from sponsor)		 Atopic Dermatitis
Related terms Dermatitis, Atopic
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov